Discontinuation report ALPHAGAN
| Report ID | 150885 |
| Drug Identification Number | 02236876 |
| Brand name | ALPHAGAN |
| Common or Proper name | ALPHAGAN 0.2% Ophthalmic Solution brimonidine tartrate |
| Company Name | ABBVIE CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | BRIMONIDINE TARTRATE |
| Strength(s) | 0.2% |
| Dosage form(s) | LIQUID |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 10mL |
| ATC code | S01EA |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2022-06-01 |
| Actual discontinuation date | |
| Remaining supply date | 2022-06-01 |
| Discontinuation status | Reversed |
| Discontinuation decision reversal | Yes |
| Information on remaining supply | |
| Company comments | 5mL package size available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
| Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-12-14 | French | Compare |
| v4 | 2023-12-14 | English | Compare |
| v3 | 2021-12-09 | French | Compare |
| v2 | 2021-12-09 | French | Compare |
| v1 | 2021-12-09 | English | Compare |
Showing 1 to 5 of 5